Mealey's (July 28, 2022, 9:24 AM EDT) -- WASHINGTON, D.C. — A District of Columbia U.S. Court of Appeals panel on July 26 denied four vape companies’ consolidated petitions for review of the Food and Drug Administration’s marketing denial orders (MDOs) banning their products from the market, finding that the FDA’s error in not reviewing the companies’ individual marketing plans was “harmless” because other data showed that the risk of youth use outweighed the products’ benefits to adult smokers....